Health systems can use electronic health record data to target households rather than just individuals, authors say. HealthDay News — Diabetes risk is commonly clustered within households, according ...

The Signos Glucose Monitoring System is a mobile device application that receives data from an OTC integrated continuous glucose monitor, the Dexcom Stelo Biosenor.

Signs and symptoms linked with withdrawal are relatively consistent in pediatric population; can be seen after five or more days of opioids ...

HealthDay News — Patients with advanced desmoplastic melanoma have high response to single-agent anti-programmed death protein 1 (PD-1) therapy, according to a study published online August 14 in ...

Cassandra Pingali, MPH, from the CDC in Atlanta, and colleagues analyzed data from the 2024 National Immunization Survey-Teen to examine national, state, and selected local area vaccination coverage ...

Improved functional, survival outcomes seen with risdiplam treatment before development of clinical signs or symptoms.

The new AAP schedule provides guidance for routine immunization against 18 diseases, including updates for RSV, influenza, and COVID-19 immunization.

The original NDA submission included data from the registration-directed phase 3 MOVE-FA trial as well as 2 long-term studies evaluating vatiquinone in FA.

The Food and Drug Administration has granted Fast Track designation to pemvidutide for the treatment of alcohol use disorder.

Semaglutide linked to increased risk of nonarteritic anterior ischemic optic neuropathy, but evidence remains insufficient to establish definitive conclusion.

ADX-2191 is a preservative-free intravitreal formulation of methotrexate designed to treat various rare retinal diseases such as retinitis pigmentosa.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ifinatamab deruxtecan for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) ...